{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:54:28Z","timestamp":1787986468443,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":266,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["2019 FI_B2 00165"],"award-info":[{"award-number":["2019 FI_B2 00165"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018\\u2013094579-B-I00"],"award-info":[{"award-number":["RTI2018\\u2013094579-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018"],"award-info":[{"award-number":["RTI2018"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["094579-B-I00"],"award-info":[{"award-number":["094579-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jconrel.2021.01.028","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T11:10:18Z","timestamp":1611400218000},"page":"364-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment"],"prefix":"10.1016","volume":"331","author":[{"given":"Arnau","family":"Biosca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Cabanach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthanna","family":"Abdulkarim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gumbleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"G\u00f3mez-Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Bouz\u00f3n-Arn\u00e1iz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunuen","family":"Avalos-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Borros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Fern\u00e0ndez-Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.01.028_bb0005","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2174\/138945012802002302","article-title":"Nanotools for the delivery of antimicrobial peptides","volume":"13","author":"Urb\u00e1n","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/09298673113206660292","article-title":"Nanomedicine against malaria","volume":"21","author":"Urb\u00e1n","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ddr.21010","article-title":"Malaria intervention policies and pharmaceutical nanotechnology as a potential tool for malaria management","volume":"73","author":"Kuntworbe","year":"2012","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","article-title":"ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model","volume":"145","author":"Moles","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2016.09.006","article-title":"Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum-infected red blood cells","volume":"241","author":"Moles","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/1556-276X-6-620","article-title":"Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors","volume":"6","author":"Urb\u00e1n","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","article-title":"A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro","volume":"151","author":"Urb\u00e1n","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0040","doi-asserted-by":"crossref","first-page":"24368","DOI":"10.1038\/srep24368","article-title":"Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium","volume":"6","author":"Marques","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nano.2016.09.010","article-title":"Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery","volume":"13","author":"Marques","year":"2017","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells","volume":"10","author":"Marques","year":"2014","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/pharmaceutics10040225","article-title":"Polyamidoamine nanoparticles for the oral administration of antimalarial drugs","volume":"10","author":"Mart\u00ed Coma-Cros","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2013.12.032","article-title":"Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium","volume":"177","author":"Urb\u00e1n","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0065","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/ijms19051361","article-title":"Antimalarial activity of orally administered curcumin incorporated in Eudragit\u00ae-containing liposomes","volume":"19","author":"Mart\u00ed Coma-Cros","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0070","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1016\/j.biomaterials.2013.07.089","article-title":"A review of the biomaterials technologies for infection-resistant surfaces","volume":"34","author":"Campoccia","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.bioeng.6.040803.140027","article-title":"Biomaterials: where we have been and where we are going","volume":"6","author":"Ratner","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0080","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1021\/nn202458g","article-title":"The evolution of the protein corona around nanoparticles: a test study","volume":"5","author":"Lundqvist","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0085","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1021\/ja910675v","article-title":"What the cell \u201csees\u201d in bionanoscience","volume":"132","author":"Walczyk","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0090","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","article-title":"Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier","volume":"47","author":"Wang","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0095","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0110","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0115","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0120","doi-asserted-by":"crossref","first-page":"742895","DOI":"10.1155\/2011\/742895","article-title":"Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy","volume":"2011","author":"Guo","year":"2011","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/annonc\/mdf157","article-title":"EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx\u00ae, Doxil\u00ae) at a 6-week interval in patients with metastatic breast cancer","volume":"13","author":"Hamilton","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nchem.1230","article-title":"Drug delivery: relieving PEGylation","volume":"4","author":"Parrott","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0005-2736(83)90093-7","article-title":"Effect of poly(ethylene glycol) on the polarity of aqueous solutions and on the structure of vesicle membranes","volume":"733","author":"Herrmann","year":"1983","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0006-3495(98)77849-X","article-title":"Hydration of polyethylene glycol-grafted liposomes","volume":"74","author":"Tirosh","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0169-409X(95)00027-5","article-title":"Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery","volume":"16","author":"Bedu-Addo","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Pt B","key":"10.1016\/j.jconrel.2021.01.028_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","article-title":"Peptide and protein PEGylation: a review of problems and solutions","volume":"22","author":"Veronese","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nbt.2580","article-title":"Zwitterionic hydrogels implanted in mice resist the foreign-body reaction","volume":"31","author":"Zhang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.reactfunctpolym.2017.07.006","article-title":"Applications of zwitterionic polymers","volume":"118","author":"Zheng","year":"2017","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0180","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1021\/la300394c","article-title":"Investigation of the hydration of nonfouling material poly(sulfobetaine methacrylate) by low-field nuclear magnetic resonance","volume":"28","author":"Wu","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0185","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/la203827h","article-title":"Investigation of the hydration of nonfouling material poly(ethylene glycol) by low-field nuclear magnetic resonance","volume":"28","author":"Wu","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0190","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1016\/j.polymer.2010.08.022","article-title":"Surface hydration: principles and applications toward low-fouling\/nonfouling biomaterials","volume":"51","author":"Chen","year":"2010","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0195","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/adma.200901407","article-title":"Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications","volume":"22","author":"Jiang","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0200","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/la500057j","article-title":"Zwitteration: coating surfaces with zwitterionic functionality to reduce nonspecific adsorption","volume":"30","author":"Schlenoff","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0205","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/polym6051544","article-title":"Structures and synthesis of zwitterionic polymers","volume":"6","author":"Laschewsky","year":"2014","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nantod.2016.05.006","article-title":"Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response","volume":"11","author":"Liu","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0215","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0220","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1002\/anie.201710068","article-title":"Mitigation of inflammatory immune responses with hydrophilic nanoparticles","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0225","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","article-title":"Diffusion of macromolecules and virus-like particles in human cervical mucus","volume":"81","author":"Olmsted","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0230","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0006-3495(94)80802-1","article-title":"Antibody diffusion in human cervical mucus","volume":"66","author":"Saltzman","year":"1994","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0235","doi-asserted-by":"crossref","first-page":"25444","DOI":"10.1021\/acsami.6b08183","article-title":"Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers","volume":"8","author":"Shan","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0240","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0245","series-title":"The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease","first-page":"453","article-title":"Pharmacokinetics and pharmacodynamics of curcumin","author":"Sharma","year":"2007"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1358\/dot.2010.46.7.1509560","article-title":"Curcumin therapeutic promises and bioavailability in colorectal cancer","volume":"46","author":"Shehzad","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0255","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bjid.2013.03.004","article-title":"Modulation of cerebral malaria by curcumin as an adjunctive therapy","volume":"17","author":"Jain","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0260","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1475-2875-10-S1-S10","article-title":"The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria","volume":"10","author":"Mimche","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0265","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/AAC.50.5.1859-1860.2006","article-title":"Curcumin-artemisinin combination therapy for malaria","volume":"50","author":"Nandakumar","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0270","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbrc.2004.11.051","article-title":"Curcumin for malaria therapy","volume":"326","author":"Reddy","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0275","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0035-9203(97)90110-3","article-title":"An alternative to serum for cultivation of Plasmodium falciparum in vitro","volume":"91","author":"Cranmer","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0280","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0285","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0290","series-title":"Functional Polymers for Nanomedicine","first-page":"227","article-title":"Zwitterionic polymers for targeted drug delivery","author":"Lin","year":"2013"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0295","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1021\/cr020371t","article-title":"Synthesis and solution properties of zwitterionic polymers","volume":"102","author":"Lowe","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0300","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1039\/C6PY01220E","article-title":"Effect of the zwitterion structure on the thermo-responsive behaviour of poly(sulfobetaine methacrylates)","volume":"8","author":"Hildebrand","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0305","series-title":"Stimuli-Responsive Water Soluble and Amphiphilic Polymers","first-page":"1","article-title":"Stimuli responsive water-soluble and amphiphilic (co)polymers","author":"Lowe","year":"2000"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#","article-title":"Well-defined sulfobetaine-based statistical copolymers as potential antibioadherent coatings","volume":"52","author":"Lowe","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0315","unstructured":"World Health Organization. Guidelines for the Treatment of Malaria, 3rd edition. http:\/\/apps.who.int\/iris\/bitstream\/10665\/162441\/1\/9789241549127_eng.pdf. 2015. Geneva, Switzerland, World Health Organization."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0320","doi-asserted-by":"crossref","first-page":"64R","DOI":"10.1203\/PDR.0b013e3181a0977e","article-title":"Resistance to antimalarial drugs: molecular, pharmacological and clinical considerations","volume":"65","author":"Travassos","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001169","article-title":"The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites","volume":"9","author":"Delves","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.jconrel.2021.01.028_bb0335","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1182\/blood-2009-09-243725","article-title":"Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites","volume":"115","author":"Boyle","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0340","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1039\/c2nr32821f","article-title":"Demonstration of specific binding of heparin to Plasmodium falciparum-infected vs non-infected red blood cells by single-molecule force spectroscopy","volume":"5","author":"Valle-Delgado","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0345","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.biomaterials.2014.05.061","article-title":"Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs","volume":"35","author":"Movellan","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.01.028_bb0350","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2015.05.284","article-title":"Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic\/prophylactic antimalarial strategy","volume":"210","author":"Moles","year":"2015","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:39:05Z","timestamp":1777509545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":70,"alternative-id":["S0168365921000377"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}